|
Press Releases |
|
 |
|
Monday, April 4, 2022 |
|
EC Healthcare Opens New Multi-Service Flagship Medical Centre at Central and Advanced Imaging Centre at Taikoo |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
Wednesday, March 9, 2022 |
|
医思健康推出遥距医疗及药物配送服务 减少外出感染风险 守护市民健康 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,为减少市民外出就医风险,集团旗下的医思健康医疗中心、智健康、汇儿儿科医务中心及纽约医疗集团的脊医及中医服务均推出遥距视像诊症服务。 more info >> |
|
醫思健康推出遙距醫療及藥物配送服務 減少外出感染風險 守護市民健康 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,為減少市民外出就醫風險,集團旗下的醫思健康醫療中心、智健康、匯兒兒科醫務中心及紐約醫療集團的脊醫及中醫服務均推出遙距視像診症服務。 more info >> |
|
EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen's Health |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce, to reduce the infection risk from going out for medical consultation more info >> |
|
医思健康主席邓志辉进一步增持公司股份 对集团发展前景充满信心 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,于2022年3月7日,集团主席、行政总裁及执行董事邓志辉先生(「邓先生」)进一步于公开市场新增购入1,000,000股,涉资逾724.6万港元,每股股份平均价格约7.2465港元。 more info >> |
|
醫思健康主席鄧志輝進一步增持公司股份 對集團發展前景充滿信心 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,於2022年3月7日,集團主席、行政總裁及執行董事鄧志輝先生(「鄧先生」)進一步於公開市場新增購入1,000,000股,涉資逾724.6萬港元,每股股份平均價格約7.2465港元。 more info >> |
|
EC Healthcare's Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group's Future Development |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group's Chairman more info >> |
|
Monday, March 7, 2022 |
|
医思健康获纳入深港通之合资格股份 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,根据深圳证券交易所于 2022年3月7日刊发的《关于深港通下的港股通股票名单调整的公告》,本公司为获纳入深港通的合资格股份,自 2022年3月7日起生效。 more info >> |
|
醫思健康獲納入深港通之合資格股份 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,根據深圳證券交易所於 2022年3月7日刊發的《關於深港通下的港股通股票名單調整的公告》,本公司為獲納入深港通的合資格股份,自 2022年3月7日起生效。 more info >> |
|
EC Healthcare Included as an Eligible Stock of the Shenzhen - Hong Kong Stock Connect |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Company has been included as an eligible stock of Shenzhen-Hong Kong Stock Connect more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
中旅國際2022年全年綜合收入30.32億港元
Apr 1, 2023 11:58 HKT/SGT
|
|
|
中旅国际2022年全年综合收入30.32亿港元
Apr 1, 2023 11:57 HKT/SGT
|
|
|
China Travel International's Consolidated Revenue of HK$3,032 Million in 2022
Apr 1, 2023 11:56 HKT/SGT
|
|
|
綠地香港2022年收入266.14億,歸母淨利潤4.81億
Apr 1, 2023 11:03 HKT/SGT
|
|
|
绿地香港2022年收入266.14亿,归母净利润4.81亿
Apr 1, 2023 11:02 HKT/SGT
|
|
|
Indonesian MCI Ensures Telecommunication Access for Successful ASEAN Chairmanship 2023
Apr 1, 2023 00:00 HKT/SGT
|
|
|
ScamAdviser Coin 'Scams' the Internet for April Fools
Mar 31, 2023 22:45 HKT/SGT
|
|
|
ScamAdviser Coin 'Scams' the Internet for April Fools
Mar 31, 2023 22:45 HKT/SGT
|
|
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 21:15: JST
|
|
|
中国生物制药(1177.HK)公布2022全年业绩
Mar 31, 2023 21:13 HKT/SGT
|
|
|
中國生物製藥(1177.HK)公佈2022全年業績
Mar 31, 2023 21:12 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results
Mar 31, 2023 21:11 HKT/SGT
|
|
|
Expand Investment in Science and Technology and Empower Industry Development, Legend Holdings Realized Revenue of RMB483.7 billion by 2022
Mar 31, 2023 20:18: JST
|
|
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 20:15 HKT/SGT
|
|
|
联控2022年收入4,837亿 稳健经营 蓄力科创
Mar 31, 2023 19:22 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|